Key facts
- Nutromics’s last known valuation is $153.3M (May 2024).
- It has raised $62.5M; the latest was Later Stage VC ($4.9M) in Sep 2025.
- Notable investors include MedTech Innovator, CONNECT (San Diego), Artesian, VU Venture Partners, LaunchVic — 16 tracked in total.
- 1 investment vehicle was formed to buy Nutromics shares in the last 12 months, reporting $290K sold to 12 investors, per SEC Form D filings.
- Status: Privately Held (backing).
- ·The complete investor list — 16 names
- ·Watchlist + deal alerts for Nutromics
- ·The full record, as it builds
Funding rounds
No funding rounds for Nutromics are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
Secondary demand: investment vehicles
from SEC Form D filingsIn the last 12 months, 1 investment vehicle were formed to buy Nutromics shares, reporting $290K sold to 12 investors. Most recent filing Mar 2026. Vehicles like these are how secondary buyers pool demand for a name; a rising count is a demand signal.
About Nutromics
Developer of medical-grade diagnostics equipment designed to diagnose through their DNA-based sensor platform. The company's technology offers a wearable sensor and software that continuously monitors biomarkers for diet, sleep, stress, and exercise and delivers real-time data and new insights for an effective lifestyle change, enabling patients to take preventative measures to reduce the risk of diabetes.
- Sector
- Healthcare
- HQ
- Brunswick, Australia
- Founded
- 2017
- Employees
- 63
- Website
- nutromics.com/
- Ownership
- Privately Held (backing)
Nutromics doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Nutromics shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Nutromics in its N-PORT filings yet. We sweep new filings monthly.